Dolby Laboratories, Inc.
For the period ended Sep 26, 2025. Filed Nov 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Nov 18, 2025
DLB$64.67-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Fiscal Year Ended | |||
|---|---|---|---|
| September 26,2025 | September 27,2024 | September 29,2023 | |
| Net income including noncontrolling interest | $256,492 | $264,316 | $201,644 |
| Other comprehensive income: | |||
| Currency translation adjustments gains, net of tax benefit/(expense) of ($200), $65, and $73 | 5,367 | 15,098 | 7,574 |
| Unrealized gains on investments, net of tax benefit/(expense) of $0, ($21), and $54 | 83 | 2,775 | 3,128 |
| Unrealized gains on cash flow hedges, net of tax benefit/(expense) of ($106), ($344), and $85 | 1,251 | 197 | 4,286 |
| Total other comprehensive income, net of tax | 6,701 | 18,070 | 14,988 |
| Total comprehensive income | 263,193 | 282,386 | 216,632 |
| Less: comprehensive income attributable to noncontrolling interest | (1,505) | (2,764) | (1,319) |
| Comprehensive income attributable to Dolby Laboratories, Inc. | $261,688 | $279,622 | $215,313 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.